Transcriptional networks governing A. fumigatus virulence
控制烟曲霉毒力的转录网络
基本信息
- 批准号:10365846
- 负责人:
- 金额:$ 67.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-22 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAntifungal TherapyAspergillosisAspergillusAspergillus fumigatusAttenuatedAzole resistanceBindingBiologyBone MarrowCandida albicansCell CommunicationCellsChIP-seqDataDefectDevelopmentDiagnosisDiagnosticDiseaseEMSAElectrophoretic Mobility Shift AssayEpidermal Growth FactorEpidermal Growth Factor ReceptorEpithelial CellsFamilyFoundationsFrightGene TargetingGenesGenetic TranscriptionGenomeGoalsGrowthHemagglutininHistoplasma capsulatumHypoxiaImmunocompromised HostIn VitroIncidenceInfectionInvadedInvestigationLifeLungMediatingOrganismPathogenesisPathogenicityPathway interactionsPopulationPredispositionPreventionProteinsReactive Oxygen SpeciesRegulonResponse ElementsRoleTestingTherapeuticVaccinesVirulenceWorkchromatin immunoprecipitationexperimental studyfungusgene productgenome-widehigh riskimprovedinnovationinterestmacrophagemembermortalitymouse modelmutantnovelnovel diagnosticsnovel therapeuticsoverexpressionpromotertargeted treatmenttraittranscription factortranscriptome sequencing
项目摘要
Abstract
Invasive infections due to Aspergillus fumigatus are increasing and are still associated with unacceptably high
mortality, even with new therapies. Our understanding of A. fumigatus infection biology is limited. Among 10,180
predicted genes in the A. fumigatus genome, over 95% are uncharacterized, and fewer than 100 genes have
demonstrated roles in virulence. It is critical to identify genes that govern virulence and the pathways in which
they act because they can point to high priority targets for therapeutic and diagnostic development. We have
identified a transcriptional regulator in A. fumigatus, WrpA, that shares limited homology with Candida albicans
Wor1 and Histoplasma capsulatum Ryp1. Our preliminary data indicate that WrpA governs the capacity of A.
fumigatus to withstand macrophage killing, grow under hypoxic conditions, and invade and damage pulmonary
cells in vitro. ΔwrpA deletion mutants have highly attenuated virulence in the mouse model of invasive
aspergillosis. Using RNA-seq, we found that WrpA governs the expression of ~15% of genes in the A. fumigatus
genome, including multiple transcription factor genes. Our premise is that the WrpA is a master regulator that
governs host cell interactions and virulence. In support of this premise, our initial investigations of the WrpA
regulon have already revealed novel pathogenicity-related functions of three WrpA-dependent transcription
factors, SrbB, Fcr1, and Ndt80. Our goal is to characterize the WrpA regulon in A. fumigatus and to identify
downstream effector genes whose products mediate pathogenicity by: 1) identifying the transcription factors that
are directly regulated by WrpA and determining their roles in pathogenicity; 2) analyzing selected WrpA-
dependent transcription factors and identifying their downstream target genes; and 3) determining the function
of effector genes controlled by the WrpA regulon and investigating their roles in virulence. The results of the
experiments described in this proposal will enable us to characterize a key transcriptional regulator that governs
A. fumigatus pathogenicity and then use this information to identify downstream effector genes, the products of
which mediate host cell interactions and virulence. The results of this work will not only provide foundational
understanding of A. fumigatus virulence mechanisms, but also hold promise to identify new diagnostic,
therapeutic, and vaccine targets.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott G Filler其他文献
Scott G Filler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott G Filler', 18)}}的其他基金
Epigenomic Mechanisms & STAT Networks in Persistent CA Candidemia
表观基因组机制
- 批准号:
10551709 - 财政年份:2023
- 资助金额:
$ 67.11万 - 项目类别:
Transcriptional networks governing A. fumigatus virulence
控制烟曲霉毒力的转录网络
- 批准号:
10687125 - 财政年份:2021
- 资助金额:
$ 67.11万 - 项目类别:
C. albicans invasion and proliferation during oral infection
口腔感染期间白色念珠菌的侵袭和增殖
- 批准号:
9894647 - 财政年份:2017
- 资助金额:
$ 67.11万 - 项目类别:
11th ASM Conference on Candida and candidiasis
第 11 届 ASM 念珠菌和念珠菌病会议
- 批准号:
8257412 - 财政年份:2012
- 资助金额:
$ 67.11万 - 项目类别:
TRANSCRIPTIONAL REGULATION OF A FUMIGATUS VIRULENCE
烟菌毒力的转录调控
- 批准号:
8174490 - 财政年份:2009
- 资助金额:
$ 67.11万 - 项目类别:
CLINICAL TRIAL: INVASIVE ASPERGILLOSIS DIAGNOSIS AND PATHOGENESIS
临床试验:侵袭性曲霉病的诊断和发病机制
- 批准号:
8174531 - 财政年份:2009
- 资助金额:
$ 67.11万 - 项目类别:
相似海外基金
Mitophagy as a target for antifungal therapy
线粒体自噬作为抗真菌治疗的靶点
- 批准号:
488010 - 财政年份:2023
- 资助金额:
$ 67.11万 - 项目类别:
Operating Grants
Enhanced Antifungal Therapy to Improve Survival in Early Disseminated Cryptococcal Infection
加强抗真菌治疗可提高早期播散性隐球菌感染的生存率
- 批准号:
10621009 - 财政年份:2023
- 资助金额:
$ 67.11万 - 项目类别:
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial
儿童念珠菌血症的短期疗程与标准疗程抗真菌治疗:多中心随机对照试验
- 批准号:
10677753 - 财政年份:2022
- 资助金额:
$ 67.11万 - 项目类别:
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial
儿童念珠菌血症的短期疗程与标准疗程抗真菌治疗:一项多中心随机对照试验
- 批准号:
10487627 - 财政年份:2022
- 资助金额:
$ 67.11万 - 项目类别:
(1-3)-beta-D-glucan guided early termination of antifungal therapy in ICU patients
(1-3)-β-D-葡聚糖指导 ICU 患者提前终止抗真菌治疗
- 批准号:
400727961 - 财政年份:2018
- 资助金额:
$ 67.11万 - 项目类别:
Research Grants
Evaluation of CRAG screening with enhanced antifungal therapy for asymptomatic CRAG-positive persons
对无症状 CRAG 阳性者进行强化抗真菌治疗的 CRAG 筛查评估
- 批准号:
10341089 - 财政年份:2018
- 资助金额:
$ 67.11万 - 项目类别:
Directed Antifungal Therapy for HIV-associated Cryptococcal Meningitis
HIV 相关隐球菌性脑膜炎的定向抗真菌治疗
- 批准号:
8991829 - 财政年份:2015
- 资助金额:
$ 67.11万 - 项目类别:
Targeting hybrid histidine kinase for broad spectrum antifungal therapy
靶向混合组氨酸激酶进行广谱抗真菌治疗
- 批准号:
7936212 - 财政年份:2009
- 资助金额:
$ 67.11万 - 项目类别:
Targeting hybrid histidine kinase for broad spectrum antifungal therapy
靶向混合组氨酸激酶进行广谱抗真菌治疗
- 批准号:
7812372 - 财政年份:2009
- 资助金额:
$ 67.11万 - 项目类别:
Optimizing antifungal therapy for HIV-associated cryptococcal meningitis in Africa
优化非洲艾滋病毒相关隐球菌性脑膜炎的抗真菌治疗
- 批准号:
G0501476/1 - 财政年份:2006
- 资助金额:
$ 67.11万 - 项目类别:
Research Grant














{{item.name}}会员




